Turkish Abstract Abstract Article PDF Similar Articles Mail to Author

¹M.D. Asistant Professor, Dicle University Faculty of Medicine, Department of Ophthalmology, Diyarbakır/TURKEY
²M.D., Dicle University Faculty of Medicine, Department of Ophthalmology, Diyarbakır/TURKEY
³M.D. Asistant Professor, Dicle University Faculty of Medicine, Department of Pediatrcs, Diyarbakır/TURKEY
⁴M.D. Associate Professor, Dicle University Faculty of Medicine, Department of Ophthalmology, Diyarbakır/TURKEY Purpose: To determine the frequency of retinopathy of prematurity (ROP) and the results of the treatment with argon laser photocoagulation (ALP) and intravitreal bevacizumab (IVB) injection.
Material and Methods: The records of the premature babies were retrospectively evaluated between June 2010 and May 2011. Birth weight, gestational age, retinopathy grade and zone were investigated. Indirect ALP ± IVB were performed when prethreshold ROP was detected.
Results: The records of 285 premature babies were evaluated. Of them, 150 were male, and 135 were female. Mean gestational age was 29.9±3.1 weeks and mean birth weight was 1443±518 g. ROP was detected in 180 patients. Sixty eyes of 30 patients were treated with ALP. Eight eyes of 5 patients were treated with adjuvant IVB. In patients with lower gestational age and lower birth weight, the stage of the ROP was more advanced (p<0.001). ROP was regressed in 28 of 30 patients after treatment. Retinal detachment developed in 2 eyes of 2 patients, who had previously diagnosed as threshold disease.
Conclusion: the results of ALP treatment at the prethreshold disease were successful, and the complications were lower. Adjuvant treatment with IVB is very effective and promising, especially in eyes with hazy media and/or refractory to the ALP treatment. Keywords : Retinopathy of prematurity, laser photocoagulation, intravitreal bevacizumab